SPharm’s Latest News
April 2011
SPharm
is pleased to be featured in the April edition of the European Life
Science Journal. In an editorial entitled "Your Partner in
North America", President Susanne Picard discusses the advantages
for European pharmaceutical/biotechnological companies to
collaborate with SPharm for their dossiers submissions in
Canada and the US. The article is available at the following
link: http://life-science.se/se.
January
2011
SPharm will be present at the 2011 BIO International Convention in Washington
D.C., June 27-30. To meet with us during the event, please email at
info@spharm.ca.
SPharm
has recently developed a new consultation service for accident
victims in cases of medical liability claims. This service
consists of the evaluation of the treatment (medication, medical
devices) prescribed with the aim of providing a professional,
objective and impartial opinion to the applicant for its acceptance
as a treatment related to the condition of the patient seeking
compensation. For more information, please do not hesitate to
communicate with us.
May 2010
SPharm joined the 2010 BIO International
Convention in Chicago.
March
2010
SPharm was nominated as a finalist of the
prestigious Mercuriades Competition in the "Market
Development" category. This competition, organized by
Quebec's Federation of Chambers of commerce, is intended to
highlight and promote the success of Quebec businesses at a
provincial, national and international level.
SPharm joined
the 22nd Annual
EuroMeeting (DIA) in Monaco.
February 2010
SPharm
attended the Canadian Institute's congress "Clinical Trials in
Canada" in Toronto.
Susanne Picard,
President, participated, as a speaker, to the
conference "Managing legal and business risks in Clinical Trials in
Canada".
November
2009
SPharm welcomed a new Specialist, Regulatory
Affairs, Sabrina Turgeon. Sabrina's polyvalence brought by her
knowledge in science as well as pharmaceutical
administration will be very useful for SPharm. Sabrina has
also developed aptitudes for oral communication (French and English)
following her participation in many national scientific
meetings.
Sabrina holds a Master degree in Cellular
Biology and a Bachelor degree in Pharmacology from Sherbrooke
University, Quebec.
June
2009
SPharm joined the "Drug Information
Association" (DIA) for the 45th Annual
Meeting in San Diego.
May 2009
SPharm
offices were officially relocated to1235,
3rd Avenue, Val-d’Or, Quebec, J9P
6C3 in order to respond to the
increasing needs of the company.
Contact
information remains the same:
Phone:
(819) 824-6869
Fax: (819)
824-4876
March
2009
SPharm joined the Strategy Institute for a conference
"Quality & Regulatory Strategies" in Toronto.
February
2009
In February
2009, SPharm welcomed a new Director of Business
Development, Mylène Lavoie.
Before joining SPharm, Mylène worked as a Project Manager
in Business Development for Oceanova Biotechnologies, a company
specialized in the development and the marketing of nutraceutic and
cosmeceutic active ingredients. Mylène also worked in cooperation
with one of the leaders of the pharmaceutical field, Glaxo Smith
Kline.
Mylène holds a MBA in Pharmaceutical
Management (Université Laval,
Quebec) and a Bachelor degree in
Microbiology/Immunology (Université de Montréal, Quebec).
June
2008
SPharm joined the Canadian Association of
Professional Regulatory Affairs (CAPRA) for a training session
"Progressive Licensing Admendments to the Food and Drugs Act" in
Montreal.
March 2008
SPharm
joined Insight for a conference "E-Clinical Trials in
Canada" in Montreal.
October
2007
SPharm
joined Insight for a congress "Clinical Trials in
Canada" in Toronto.
Insight is a conference provider company which offers business
information to professionals across North
America.
Spring 2007
In spring 2007 SPharm took part, within a strategic
alliance, in a Biopharma mission in Brussels and Lille.
SPharm is part of a strategic alliance of five (5)
Canadian expertise services companies in the biopharmaceutical
field. These companies represent an excellent potential of
partnership for biopharmaceutical companies who require expertise
services during their drug development process. All 5 companies,
part of the strategic Alliance, offer complementary
expertise services that cover each stage of products development,
from the end of pre-clinical phase, all the way through the Canadian
marketing of the products after regulatory approvals.
The objective of the Brussels/Lille’s mission was to
demystify the differences between Health Canada’s regulatory
requirements and those of the United States Food and Drug
Administration (FDA) and the European Medicines Agency (EMEA) in
order to encourage European companies to establish a strategic
partnership with the Alliance for the development and marketing of
their products in Canada and in North America.
April 2006
Following its nomination
by the Chamber of Commerce of Val-d’Or, (2 categories: Development
of New Markets and Young Enterprise), the SPharm team had the
immense pleasure of being honoured in April 2006, during the annual
gala of the Chamber of Commerce, by the attribution of two Awards
namely, the first prize for "Development of New
Markets", as well as the most prestigious award
"Enterprise of the year".
This reward, honours the
successful development of SPharm, and reflects our commitment to
always provide our clients with quality services. It is the result
of successful business partnerships that are built on
confidence.
Back row:
Pascale
Bélisle, Regulatory Specialist
Marie-Claude Gravel, Regulatory Specialist
Sonia
Varalo, Receptionist and archive coordination
Front
row:
Carmen
Perron, Assistant Accountant
Susanne
Picard, President
Ginette Plante,
Administrative Assistant and document coordination
Sylvie
Ducharme, Director, Business Development.
November 2005 and February 2006
SPharm was recently
given two opportunities to present to American counterparts the
overall Canadian regulatory process for the approval of clinical
trials in Canada
, as well as differences with the USA FDA
process for IND
approvals.
In November 2005,
SPharm participated in a Symposium presented at the Canadian
Consulate in Boston , which presented
the benefits of conducting clinical trials in Canada
. The audiences for this event were
representatives of the Biotechnology industry specialized in
Oncology.
SPharm was then invited
by the Québec Government House in New York
to participate in February 2006
in a symposium entitled: "Maximizing the
outcome of clinical trials", which was held in Newark , NJ , for various pharmaceutical
companies of this specific area.
